| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
MILFORD, Mass.—Building on a two-year-old co-marketing partnership, Waters Corp. and Rosetta Biosoftware announced last month the integration of the Waters IdentityE search engine with the Rosetta Elucidator system. The integration extends the capabilities of the Elucidator system for Waters' customers by allowing MSE data generated on Waters' instrumentation to be processed qualitatively as well as quantitatively.

The announcement, made at the American Society for Mass Spectrometry (ASMS) conference in Denver last month, is the culmination of a collaboration that began in 2006 in which Rosetta imported and processed Waters' proteomics UPLC-MSE accurate mass data into its Elucidator system for relative quantification studies. Finding that the Elucidator system's quantitative study capabilities were useful to its customers but lacked the qualitative protein identification capabilities required by some researchers, the companies decided to upgrade data interrogation and visualization tools within the Elucidator system to leverage Waters' data format.

Tim Riley, vice president and managing director of Waters' Pharmaceutical Business Operations, says the integrated products create a "powerhouse solution" for both companies' proteomics customers.

"Both Waters and Rosetta Biosoftware firmly believe that robust informatics are absolutely critical to the meaningful interpretation of data from complex biological systems produced by state-of-the-art analytical instrumentation," Riley says.

Rosetta General Manager Yelena Shevelenko says the agreement is in line with both companies' commitment to provide flexible and interoperable software platforms for their customers.

"Collaboration with instrument vendors is a core strategy for Rosetta Biosoftware. Therefore, the partnership with Waters was a natural fit," Shevelenko says.

The Elucidator system allows users to organize, search for and retrieve raw and processed protein expression data. Users can incorporate organization-specific workflows into customized visual scripts that leverage Elucidator system statistical tools, customer-proprietary algorithms and information in the public domain.

IdentityE incorporates comprehensive peptide ion accounting informatics that visualize and identify peptides and proteins with a multi-layered physicochemical model of protein primary structure. The solution enables proteomics researchers to reference chromatographic retention time, exact precursor and product ion masses, structural significance, biological context and plausible detection of multiple peptides to identify a protein.

Customer response has been strong, as the integrated solution was used in a large number of presented studies at the ASMS conference, Shevelenko says.

"Our goal was to develop a revolutionary software product for proteomics researchers to enable their drug discovery efforts," she says. "We will continue to evaluate how we can collaborate to grow our individual and mutual goals of enabling researchers in the life science and drug discovery arena." DDN

About the Author

Related Topics

Published In

Volume 4 - Issue 7 | July 2008

July 2008

July 2008 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue